jCyte Launches New Phase 2 Clinical Trial for its Cell-Based RP Therapy

https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/5d/2a/05/5d2a05d6-9e8f-ebde-5b02-4e7f17c31d76/mza_720905515349598464.jpg/600x600bb.jpg

Foundation Fighting Blindness

238 episodes

2 weeks ago

The Foundation funded preclinical studies for the approach and launched Opus.

All content for Foundation Fighting Blindness is the property of Foundation Fighting Blindness and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

The Foundation funded preclinical studies for the approach and launched Opus.

Science

https://i1.sndcdn.com/artworks-CXfadvG0jbsengY3-KyAn9g-t3000x3000.png

jCyte Launches New Phase 2 Clinical Trial for its Cell-Based RP Therapy

Foundation Fighting Blindness

3 minutes 7 seconds

3 months ago

jCyte Launches New Phase 2 Clinical Trial for its Cell-Based RP Therapy

The trial is evaluating a cell dose that is 50 percent higher than the highest dose used in a previous Phase 2b trial.